BIOTECHNOLOGY VALUE FUND L P - 10 Feb 2026 SCHEDULE 13G Report for SUTRO BIOPHARMA, INC. Common Stock, $0.001 par value (STRO)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
SUTRO BIOPHARMA, INC. Common Stock, $0.001 par value
Symbol
STRO
Shares outstanding
16,470,895 shares
Disclosed Ownership
1,251,788 shares
Ownership
7.6%
Form type
SCHEDULE 13G
Filing time
18 Feb 2026, 19:49:36 UTC
Date of event
10 Feb 2026
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 4.1% 668,693 0 668,693 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 4.1% 668,693 0 668,693 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 3% 488,916 0 488,916 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 3% 488,916 0 488,916 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.5% 75,359 0 75,359 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.5% 75,359 0 75,359 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 7% 1,157,609 0 1,157,609 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 7.6% 1,251,788 0 1,251,788 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 7.6% 1,251,788 0 1,251,788 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 7.6% 1,251,788 0 1,251,788 /s/ Mark N. Lampert Mark N. Lampert